In vitro recombination method

US9534251B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9534251-B2
Application numberUS-75057110-A
CountryUS
Kind codeB2
Filing dateMar 30, 2010
Priority dateAug 11, 2005
Publication dateJan 3, 2017
Grant dateJan 3, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates, e.g., to in vitro method, using isolated protein reagents, for joining two double stranded (ds) DNA molecules of interest, wherein the distal region of the first DNA molecule and the proximal region of the second DNA molecule share a region of sequence identity, comprising contacting the two DNA molecules in a reaction mixture with (a) a non-processive 5′ exonuclease; (b) a single stranded DNA binding protein (SSB) which accelerates nucleic acid annealing; (c) a non strand-displacing DNA polymerase; and (d) a ligase, under conditions effective to join the two DNA molecules to form an intact double stranded DNA molecule, in which a single copy of the region of sequence identity is retained. The method allows the joining of a number of DNA fragments, in a predetermined order and orientation, without the use of restriction enzymes.

First claim

Opening claim text (preview).

The invention claimed is: 1. A kit for in vitro joining a plurality of dsDNA molecules, consisting essentially of in a single container, a mixture of the isolated proteins (i) a single stranded DNA binding protein (SSB) which accelerates nucleic acid annealing, (ii) a non strand-displacing DNA polymerase, and (iii) a ligase; (iv) an isolated non-processive 5′ exonuclease; and (v) glycerol in an amount effective as a preservative; wherein the ratios of activities of (i), (ii), (iii), and (iv) are effective to achieve in vitro joining of dsDNA molecules, and wherein the dsDNA molecules are joined via a region of sequence homology to form a DNA molecule in which a single copy of the region of sequence homology is retained. 2. The kit of claim 1 , wherein the mixture contains (i) as the SSB, the phage T7 gene 2.5 product, the E. coli recA protein, RedB of lambda phage, or RecT of Rae prophage; (ii) as the DNA polymerase, the T7 gene 5 product, T4 polymerase, or E. coli pol; and/or (iii) as the ligase, the phage T7 gene 1.3 product, phage T4 DNA ligase, or E. coli DNA ligase; and/or (iv) as the 5′ exonuclease, the phage T7 gene 6 product, RedA of lambda phage, or RecE of Rae prophage. 3. The kit of claim 2 wherein: (i) the phage T7 gene 2.5 product, the E. coli recA protein, RedB of lambda phage, or RecT of Rae prophage are substantially purified; (ii) the T7 gene 5 product, T4 polymerase, or E. coli pol are substantially purified; and/or (iii) the phage T7 gene 1.3 product, phage T4 DNA ligase, or E. coli DNA ligase are substantially purified. 4. The kit of claim 3 wherein the non-processive 5′ exonuclease is substantially purified. 5. The kit of claim 3 further comprising instructions for performing a method for the in vitro joining of a plurality of dsDNA molecules. 6. The kit of claim 1 wherein: (i) the single stranded DNA binding protein (SSB) is substantially purified; (ii) the non strand-displacing DNA polymerase is substantially purified, and (iii) the ligase is substantially purified. 7. The kit of claim 6 wherein the non-processive 5′ exonuclease is substantially purified. 8. The kit of claim 6 further comprising instructions for performing a method for the in vitro joining of a plurality of dsDNA molecules. 9. A composition consisting essentially of: (a) a substantially purified single stranded DNA binding protein (SSB) which accelerates nucleic acid annealing, (b) a substantially purified non strand-displacing DNA polymerase, (c) a substantially purified ligase, and (d) substantially purified non-processive 5′ exonuclease, and (e) glycerol in an amount effective as a preservative; wherein the ratios of activities of (a), (b), (c) and (d) are effective to achieve in vitro joining of dsDNA molecules via a region of homology.

Assignees

Inventors

Classifications

  • Exodeoxyribonuclease (lambda-induced) (3.1.11.3) · CPC title

  • DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

  • General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host · CPC title

  • General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease · CPC title

  • C12Q1/6862Primary

    Ligase chain reaction [LCR] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9534251B2 cover?
The present invention relates, e.g., to in vitro method, using isolated protein reagents, for joining two double stranded (ds) DNA molecules of interest, wherein the distal region of the first DNA molecule and the proximal region of the second DNA molecule share a region of sequence identity, comprising contacting the two DNA molecules in a reaction mixture with (a) a non-processive 5′ exonucle…
Who is the assignee on this patent?
Young Lei, Smith Hamilton O, Gibson Daniel Glenn, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12Q1/6862. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).